Leukemia Clinical Trials in Nashville

Showing 581-600 of 1,521 trials

A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

NCT04072458

This study evaluates the safety, pharmacokinetics, and efficacy of BP1002 (L-Bcl-2) antisense oligonucleotide in patients with advanced lymphoid malignancies. Up to 12 evaluable patients with a diagnosis of relapsed or refractory lymphoid malignancies are expected to participate.

Mantle Cell LymphomaPeripheral T-cell Lymphoma (PTCL)Cutaneous T-cell Lymphoma (CTCL)+7 more

Bio-Path Holdings, Inc.30 participantsStarted Nov 2020

Augusta, Georgia, United States • Valhalla, New York, United States • Nashville, Tennessee, United States +2 more locations

COMPLETEDPhase 3< 1 mile

LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

NCT01828112

The primary purpose of the study was to compare the antitumor activity of LDK378 vs. chemotherapy in patients previously treated with chemotherapy (platinum doublet) and crizotinib. Patients in the chemotherapy arm were given the option to switch to LDK378 after confirmed progressive disease (PD), while also had the choice to continue with pemetrexed treatment.

Non-Small Cell Lung Cancer

Novartis Pharmaceuticals231 participantsStarted Jun 2013

Fayetteville, Arkansas, United States • Hollywood, Florida, United States • Jacksonville, Florida, United States +94 more locations

A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

Leukemia Trials in Other Cities

HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

SGI-110 in Participants With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Avelumab in First-line NSCLC (JAVELIN Lung 100)

Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated

Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis

Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML

Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

Pulmonary Rehabilitation Before Lung Cancer Resection

Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors

A Study of SGN-ALPV in Advanced Solid Tumors

Bright Ideas - CIN Feasibility Study

Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors

Other Conditions in Nashville